MX2020010773A - Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios. - Google Patents

Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios.

Info

Publication number
MX2020010773A
MX2020010773A MX2020010773A MX2020010773A MX2020010773A MX 2020010773 A MX2020010773 A MX 2020010773A MX 2020010773 A MX2020010773 A MX 2020010773A MX 2020010773 A MX2020010773 A MX 2020010773A MX 2020010773 A MX2020010773 A MX 2020010773A
Authority
MX
Mexico
Prior art keywords
intermediates
preparing
compound
pyrroloaminopyridazinone
starting materials
Prior art date
Application number
MX2020010773A
Other languages
English (en)
Inventor
Wei Jiang
Zhongjun Guan
Jian Huang
Lingjian Zhu
Original Assignee
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co filed Critical Jiangsu Hengrui Medicine Co
Publication of MX2020010773A publication Critical patent/MX2020010773A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/42—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/32—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups bound to acyclic carbon atoms and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems

Abstract

La presente invención se refiere a un método para preparar un compuesto de pirroloaminopiridazinona e intermedios del mismo. Específicamente relacionado con un método para preparar el compuesto de fórmula (I), el producto objetivo se prepara mediante el cambio de materiales de partida e intermedios; el presente método tiene las ventajas de reactivos tales como que los materiales de partida son fáciles de adquirir, las condiciones de reacción son simples y controlables, el método de tratamiento posterior a la reacción es simple, el rendimiento es alto y es beneficioso para la producción industrial. (ver Fórmula).
MX2020010773A 2018-04-13 2019-04-12 Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios. MX2020010773A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810328604 2018-04-13
PCT/CN2019/082367 WO2019196915A1 (zh) 2018-04-13 2019-04-12 一种吡咯并氨基哒嗪酮化合物的制备方法及其中间体

Publications (1)

Publication Number Publication Date
MX2020010773A true MX2020010773A (es) 2021-03-02

Family

ID=68163088

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020010773A MX2020010773A (es) 2018-04-13 2019-04-12 Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios.

Country Status (11)

Country Link
US (1) US20210147428A1 (es)
JP (1) JP2021521208A (es)
KR (1) KR20200144546A (es)
CN (1) CN111094274A (es)
AU (1) AU2019251278A1 (es)
BR (1) BR112020020876A2 (es)
CA (1) CA3096414A1 (es)
MX (1) MX2020010773A (es)
TW (1) TW201943711A (es)
WO (1) WO2019196915A1 (es)
ZA (1) ZA202006128B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021057998A1 (zh) * 2019-09-29 2021-04-01 上海森辉医药有限公司 一种吡咯并氨基哒嗪酮化合物的制备方法
CN112745255A (zh) * 2019-10-30 2021-05-04 江苏恒瑞医药股份有限公司 一种btk激酶抑制剂的制备方法
CN114751850B (zh) * 2022-06-06 2023-08-25 上海再启生物技术有限公司 一种btk激酶抑制剂关键中间体的制备方法
CN114989062A (zh) * 2022-07-04 2022-09-02 上海再启生物技术有限公司 一种btk激酶抑制剂中间体的晶型及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
CN103848810A (zh) * 2012-11-30 2014-06-11 北京赛林泰医药技术有限公司 鲁顿酪氨酸激酶抑制剂
BR112017000470B1 (pt) 2014-07-07 2022-11-29 Jiangsu Hengrui Medicine Co., Ltd Compostos, composição farmacêutica e uso do composto ou da composição
CN105837576B (zh) * 2015-01-14 2019-03-26 湖北生物医药产业技术研究院有限公司 Btk抑制剂
CN106939002B (zh) * 2016-01-05 2019-09-24 江苏恒瑞医药股份有限公司 一种btk激酶抑制剂的结晶形式及其制备方法
BR112018012106B1 (pt) * 2016-01-05 2023-12-12 Jiangsu Hengrui Medicine Co., Ltd Forma cristalina i de (r)-4-amino-1-(1-(but-2-inoil)pirrolidin-3-il)-3-(4- (2,6- difluorofenoxi)fenil)-1h-pirrolo[2,3-d]piridazin-7(6h)-ona, método de preparar a forma cristalina i, composição farmacêutica e uso da forma cristalina i

Also Published As

Publication number Publication date
US20210147428A1 (en) 2021-05-20
EP3778591A1 (en) 2021-02-17
WO2019196915A1 (zh) 2019-10-17
ZA202006128B (en) 2022-01-26
JP2021521208A (ja) 2021-08-26
KR20200144546A (ko) 2020-12-29
CA3096414A1 (en) 2019-10-17
TW201943711A (zh) 2019-11-16
AU2019251278A1 (en) 2020-10-08
CN111094274A (zh) 2020-05-01
BR112020020876A2 (pt) 2021-01-26

Similar Documents

Publication Publication Date Title
MX2020010773A (es) Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios.
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
MX2020006306A (es) Método novedoso para producir 4,5-dihidroisoxazol 5,5-disustituido.
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
EA202091466A1 (ru) Синтез сокристалла 1:1:1 1-циано-2-(4-циклопропилбензил)-4-(-d-глюкопираноз-1-ил)бензола, l-пролина и воды
TN2019000301A1 (en) Method for preparing intermediate of 4-methoxypyrrole derivative
NZ773997A (en) Method for producing 4-methoxy pyrrole derivative
MX2020011267A (es) Metodo de produccion para 4,5-dihidroisoxazol 5,5-disustituido.
MX2018014128A (es) 6.7.beta-epoxidos esteroideos como intermedios quimicos.
NZ747549A (en) Method for preparing azoxystrobin intermediates
MX2021002064A (es) Metodo de preparacion del compuesto pirrolo-amino-piridazinona e intermedio del mismo.
MX2022001495A (es) Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble.
EA201201666A1 (ru) Промежуточные соединения агомелатина и способ их получения
JOP20180126A1 (ar) عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان
MX2018004631A (es) Proceso industrial para la preparación de la sal de (e)-3-carboxiacrilato de (5s,10s)-10-bencil-16-metil-11,14,18-trio xo-15,17,19-trioxa-2,7,8-tritia-12-azahenicosan-5-aminio.
MX2023000044A (es) Nuevos procesos e intermediarios para la preparacion de estimulantes de guanilato ciclasa soluble.
MX2022002017A (es) Metodo para producir derivado de heterociclideno acetamida.
EP4249491A3 (en) Process for preparing bicyclic enolether
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
MX2021008323A (es) Preparacion de 5-aril pentanoles.
WO2016079759A4 (en) Novel single step esterification process of aldehydes using a heterogeneous catalyst
MX2021011548A (es) Proceso novedoso para la preparacion de filgotinib e intermediarios del mismo.
WO2016071920A3 (en) A process for preparation of 3,4-dimethylbenzaldehyde
WO2015170600A1 (ja) ５－（トリフルオロメチル）ピリミジン誘導体及びその製造方法